Pharmaceutical industry funding of educational events for pharmacists in Australia: An analysis of data from the first 6 months of a mandatory disclosure programme

Jane Robertson, Emily Walkom, Ray Moynihan, Lisa Bero, David Henry

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

OBJECTIVE: The aim of the study was to assess the extent of pharmacist participation in pharmaceutical industry-sponsored educational events in Australia.

METHODS: A descriptive analysis was performed of 14 649 educational events provided by 43 companies between July and December 2007, using publicly available reports posted on the Medicines Australia website. Pharmacist participation was assessed according to duration and type of event, whether continuing professional education credits were awarded, type of venue, hospitality provided and cost of hospitality.

KEY FINDINGS: Most of the 14 649 industry-sponsored events reported in this mandatory reporting programme were targeted at doctors (specialists and general practitioners). Pharmacists were present at 621 events (4.2%); 209 events were pharmacist-only events. Of pharmacist-only events, 68% were held in hospitals and professional rooms and 13% in restaurants. In contrast, 32% of events involving doctors were held in restaurants (difference in proportions 18.9%; 95% confidence interval 13.5-22.9%) Sixty-six per cent of pharmacist-only events were 1 h or less in duration; 81% were 2 h or less. Almost 40% were reported as training or in-service activities, generally conducted in hospitals. Only three events had continuing professional education credits assigned. The most common topics discussed were oncology, diabetes, haematology, cardiology and gastroenterology; a specific medicine was mentioned in the descriptor for 23 of the 209 (11%) events. Hospitality provided was generally modest, averaging AU$36.24 per pharmacist across all pharmacist-only events, and lower in hospital (AU$9.21 per head) than those held in restaurants (AU$51.42).

CONCLUSIONS: The data from this first report suggest pharmacists were not a major target for industry-funded educational events. Exposure to such events will likely increase as pharmacists take on enhanced prescribing roles and it is important that this is captured under the mandatory disclosure requirements that have been introduced in a number of jurisdictions. It is also desirable that such schemes include generic medicines manufacturers and that pharmacy professional bodies use these data to monitor and manage the level and impact of interactions between pharmacists and industry.

Original languageEnglish
Pages (from-to)88-92
Number of pages5
JournalInternational Journal of Pharmacy Practice
Volume18
Issue number2
DOIs
Publication statusPublished - Apr 2010
Externally publishedYes

Fingerprint

Mandatory Programs
Disclosure
Drug Industry
Pharmacists
Medicine
Pharmaceutical Preparations
Industry
Restaurants
Gastroenterology
Education
Cardiology
Oncology
Professional Education
Medical problems
Continuing Education
Websites
Mandatory Reporting
Hematology
Costs
General Practitioners

Cite this

@article{7b7b88273b794c03b5a2c2f932681302,
title = "Pharmaceutical industry funding of educational events for pharmacists in Australia: An analysis of data from the first 6 months of a mandatory disclosure programme",
abstract = "OBJECTIVE: The aim of the study was to assess the extent of pharmacist participation in pharmaceutical industry-sponsored educational events in Australia.METHODS: A descriptive analysis was performed of 14 649 educational events provided by 43 companies between July and December 2007, using publicly available reports posted on the Medicines Australia website. Pharmacist participation was assessed according to duration and type of event, whether continuing professional education credits were awarded, type of venue, hospitality provided and cost of hospitality.KEY FINDINGS: Most of the 14 649 industry-sponsored events reported in this mandatory reporting programme were targeted at doctors (specialists and general practitioners). Pharmacists were present at 621 events (4.2{\%}); 209 events were pharmacist-only events. Of pharmacist-only events, 68{\%} were held in hospitals and professional rooms and 13{\%} in restaurants. In contrast, 32{\%} of events involving doctors were held in restaurants (difference in proportions 18.9{\%}; 95{\%} confidence interval 13.5-22.9{\%}) Sixty-six per cent of pharmacist-only events were 1 h or less in duration; 81{\%} were 2 h or less. Almost 40{\%} were reported as training or in-service activities, generally conducted in hospitals. Only three events had continuing professional education credits assigned. The most common topics discussed were oncology, diabetes, haematology, cardiology and gastroenterology; a specific medicine was mentioned in the descriptor for 23 of the 209 (11{\%}) events. Hospitality provided was generally modest, averaging AU$36.24 per pharmacist across all pharmacist-only events, and lower in hospital (AU$9.21 per head) than those held in restaurants (AU$51.42).CONCLUSIONS: The data from this first report suggest pharmacists were not a major target for industry-funded educational events. Exposure to such events will likely increase as pharmacists take on enhanced prescribing roles and it is important that this is captured under the mandatory disclosure requirements that have been introduced in a number of jurisdictions. It is also desirable that such schemes include generic medicines manufacturers and that pharmacy professional bodies use these data to monitor and manage the level and impact of interactions between pharmacists and industry.",
author = "Jane Robertson and Emily Walkom and Ray Moynihan and Lisa Bero and David Henry",
year = "2010",
month = "4",
doi = "10.1211/ijpp.18.02.0003",
language = "English",
volume = "18",
pages = "88--92",
journal = "International Journal of Pharmacy Practice",
issn = "0961-7671",
publisher = "Pharmaceutical Press",
number = "2",

}

Pharmaceutical industry funding of educational events for pharmacists in Australia : An analysis of data from the first 6 months of a mandatory disclosure programme. / Robertson, Jane; Walkom, Emily; Moynihan, Ray; Bero, Lisa; Henry, David.

In: International Journal of Pharmacy Practice, Vol. 18, No. 2, 04.2010, p. 88-92.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Pharmaceutical industry funding of educational events for pharmacists in Australia

T2 - An analysis of data from the first 6 months of a mandatory disclosure programme

AU - Robertson, Jane

AU - Walkom, Emily

AU - Moynihan, Ray

AU - Bero, Lisa

AU - Henry, David

PY - 2010/4

Y1 - 2010/4

N2 - OBJECTIVE: The aim of the study was to assess the extent of pharmacist participation in pharmaceutical industry-sponsored educational events in Australia.METHODS: A descriptive analysis was performed of 14 649 educational events provided by 43 companies between July and December 2007, using publicly available reports posted on the Medicines Australia website. Pharmacist participation was assessed according to duration and type of event, whether continuing professional education credits were awarded, type of venue, hospitality provided and cost of hospitality.KEY FINDINGS: Most of the 14 649 industry-sponsored events reported in this mandatory reporting programme were targeted at doctors (specialists and general practitioners). Pharmacists were present at 621 events (4.2%); 209 events were pharmacist-only events. Of pharmacist-only events, 68% were held in hospitals and professional rooms and 13% in restaurants. In contrast, 32% of events involving doctors were held in restaurants (difference in proportions 18.9%; 95% confidence interval 13.5-22.9%) Sixty-six per cent of pharmacist-only events were 1 h or less in duration; 81% were 2 h or less. Almost 40% were reported as training or in-service activities, generally conducted in hospitals. Only three events had continuing professional education credits assigned. The most common topics discussed were oncology, diabetes, haematology, cardiology and gastroenterology; a specific medicine was mentioned in the descriptor for 23 of the 209 (11%) events. Hospitality provided was generally modest, averaging AU$36.24 per pharmacist across all pharmacist-only events, and lower in hospital (AU$9.21 per head) than those held in restaurants (AU$51.42).CONCLUSIONS: The data from this first report suggest pharmacists were not a major target for industry-funded educational events. Exposure to such events will likely increase as pharmacists take on enhanced prescribing roles and it is important that this is captured under the mandatory disclosure requirements that have been introduced in a number of jurisdictions. It is also desirable that such schemes include generic medicines manufacturers and that pharmacy professional bodies use these data to monitor and manage the level and impact of interactions between pharmacists and industry.

AB - OBJECTIVE: The aim of the study was to assess the extent of pharmacist participation in pharmaceutical industry-sponsored educational events in Australia.METHODS: A descriptive analysis was performed of 14 649 educational events provided by 43 companies between July and December 2007, using publicly available reports posted on the Medicines Australia website. Pharmacist participation was assessed according to duration and type of event, whether continuing professional education credits were awarded, type of venue, hospitality provided and cost of hospitality.KEY FINDINGS: Most of the 14 649 industry-sponsored events reported in this mandatory reporting programme were targeted at doctors (specialists and general practitioners). Pharmacists were present at 621 events (4.2%); 209 events were pharmacist-only events. Of pharmacist-only events, 68% were held in hospitals and professional rooms and 13% in restaurants. In contrast, 32% of events involving doctors were held in restaurants (difference in proportions 18.9%; 95% confidence interval 13.5-22.9%) Sixty-six per cent of pharmacist-only events were 1 h or less in duration; 81% were 2 h or less. Almost 40% were reported as training or in-service activities, generally conducted in hospitals. Only three events had continuing professional education credits assigned. The most common topics discussed were oncology, diabetes, haematology, cardiology and gastroenterology; a specific medicine was mentioned in the descriptor for 23 of the 209 (11%) events. Hospitality provided was generally modest, averaging AU$36.24 per pharmacist across all pharmacist-only events, and lower in hospital (AU$9.21 per head) than those held in restaurants (AU$51.42).CONCLUSIONS: The data from this first report suggest pharmacists were not a major target for industry-funded educational events. Exposure to such events will likely increase as pharmacists take on enhanced prescribing roles and it is important that this is captured under the mandatory disclosure requirements that have been introduced in a number of jurisdictions. It is also desirable that such schemes include generic medicines manufacturers and that pharmacy professional bodies use these data to monitor and manage the level and impact of interactions between pharmacists and industry.

U2 - 10.1211/ijpp.18.02.0003

DO - 10.1211/ijpp.18.02.0003

M3 - Article

VL - 18

SP - 88

EP - 92

JO - International Journal of Pharmacy Practice

JF - International Journal of Pharmacy Practice

SN - 0961-7671

IS - 2

ER -